Particle.news

Download on the App Store

Medical Community Rebukes Trump’s Tylenol–Autism Claim as FDA Issues Nuanced Advisory

Experts warn the claim risks deterring safe treatment of fever and pain in pregnancy.

Overview

  • President Trump urged pregnant women to avoid Tylenol and claimed it causes autism, while HHS and the FDA began steps toward new cautionary labeling and clinician advisories.
  • The FDA told physicians that a causal relationship between prenatal acetaminophen use and autism has not been established, advising judicious use and discouraging routine treatment of low‑grade fevers.
  • Major medical groups, including ACOG and SMFM, maintain acetaminophen remains an appropriate option in pregnancy when needed and caution that untreated fever and severe pain carry real maternal‑fetal risks.
  • Scientists whose studies were cited by the administration say their work is being misinterpreted, noting the evidence is observational and that stronger sibling‑comparison research has not found a causal link.
  • The administration’s promotion of leucovorin as an autism intervention faces skepticism due to limited data, and reporting highlights ties between Kennedy‑aligned advocates and supplement vendors marketing alternatives.